Inventor · disambiguated record
Emily Cheng
Also filed as: CHENG EMILY · CHENG EMILY H · CHENG EMILY H Y
6 granted patents·3 pending applications·32 citations·filing 2000–2016
76Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER4DANA FARBER CANCER INST INC1HSIEH JAMES1HSIEH JAMES J1UNIV JOHNS HOPKINS1
Top patents by PatentIndex Score
9 records- 0182US6570002B1Inhibitor of programmed cell deathUNIV JOHNS HOPKINS·Filed 2000·Granted May 27, 2003·26 cites·8 claims
- 0280US8501811B2TASPASE1 inhibitors and their usesHSIEH JAMES·Filed 2011·Granted Aug 6, 2013·5 cites·1 claims
- 0373US7964700B2Inhibitors of Taspase1 protease activityDANA FARBER CANCER INST INC·Filed 2007·Granted Jun 21, 2011·1 cites·24 claims
- 0456US2006068482A1Taspase1 and methods of useHSIEH JAMES J·Filed 2004·Application pending·0 cites
- 0553US2005085420A1Method of modulating apoptosis and compositions thereofFiled 2004·Application pending·0 cites
- 0651US10975051B2Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Apr 13, 2021·0 cites·25 claims
- 0747US11098021B2Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Aug 24, 2021·0 cites·25 claims
- 0833US2018335421A1Method for screening inhibitors targeting anti-apoptotic survival pathwaysMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
- 0930US10610521B2Biomarkers for response to rapamycin analogsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Apr 7, 2020·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Emily Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →